Loading company…
Rediscovery Life Sciences develops repurposed drug treatments for acute kidney injury.
Founded in 2016, Rediscovery Life Sciences develops treatments for acute kidney injury by repurposing existing drugs. It is evaluating suramin for patients with diuretic-resistant acute kidney injury. The company is based in Cambridge, US, and is at Series B stage; in September 2020, it raised USD 4.5 million co-led by Orlando Health Ventures and Rex Health Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in